Special Issue "Products from Marine Actinomycetes"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (3 July 2020) | Viewed by 10845
Interests: natural products; drug discovery; antibiotics; antimicrobial resistance; natural product biosynthesis
Special Issues, Collections and Topics in MDPI journals
The marine environment is one of the most intensively explored sources of microbial diversity and in recent years new taxonomic groups of marine actinomycetes have been described with extraordinary rich metabolic capacities. Marine-obligate and marine-derived species are one of richest sources of structurally diverse secondary metabolites. The metabolic diversity within marine actinobacteria is supported by the exponentially growing genome sequence information available from public databases. The evidence of a broad distribution of indigenous actinomycetes in the marine environment is now overwhelming as well as the presence of novel strains that have not yet been cultivated from these microbial communities.
Current technology advances and available omics platforms supporting the development of merging disciplines in synthetic biology, chemistry and microbiology are driving the exploration of the broad microbial and chemical diversities in the marine environment. All together they are paving the way to enable the discovery of novel families of bioactive compounds with potential applications in a broad range of therapeutic and biotechnology areas.
This special issue aims to cover all most recent advances in the field of marine actinomycetes natural products research and how these approaches are contributing to define novel trends in marine natural products drug discovery.
Dr. Olga Genilloud
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine natural products
- Marine actinomycetes
- Genome-based discovery